The bill aims to enhance the availability of nonopioid drugs for pain management by mandating that health plans and managed care organizations provide coverage for at least one nonopioid legend drug without the imposition of prescription drug utilization management techniques, such as prior authorization or step therapy protocols, starting January 1, 2027. The bill defines "nonopioid drug" as a drug or biological product approved by the FDA that produces analgesia without acting on opioid receptors. Additionally, it amends existing laws to incorporate these new requirements and ensure compliance across various health plans.

Furthermore, the bill requires the Department of Health to develop and publish an educational pamphlet by January 1, 2027, which will inform the public about nonopioid alternatives for pain treatment, including both medicinal and nonpharmacological therapies, as well as their advantages and disadvantages. The bill also updates the definitions related to prescription drug utilization management to include the new provisions, ensuring that the definitions align with the newly established requirements for nonopioid drug coverage.

Statutes affected:
Original bill: 48.43.400
Substitute bill: 48.43.400
Engrossed substitute: 48.43.400